Sickness and depression: when the immune method subjugates the brain. Nat Rev Neurosci 2008, 9:46?6. 27. McAfoose J, Baune BT: Proof for any cytokine model of cognitive function. Neurosci Biobehav Rev 2009, 33:355?66. 28. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Bienfait K, Dicke A, Kusnekov A: The function of inflammatory cytokines in cognition as well as other non-motor symptoms of Parkinson’s illness. Psychosomatics 2010, 51:474?79. 29. Suzuki E, Yagi G, Nakaki T, Kanba S, Asai M: Elevated plasma nitrate levels in depressive states. J Affect Disord 2001, 63:221?24. 30. McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are positive for HLA-DR inside the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 1988, 38:1285?291. 31. Gao HM, Hong JS: Why neurodegenerative ailments are progressive: uncontrolled inflammation drives illness progression. Trends Immunol 2008, 29:357?65. 32. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915?18. 33. Shen S, Yu S, Binek J, Chalimoniuk M, Zhang X, Lo SC, Hannink M, Wu J, Fritsche K, Donato R, Sun GY: Distinct signaling pathways for induction of variety II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int 2005, 47:298?07. 34. Moss DW, Bates TE: Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur J Neurosci 2001, 13:529?38.Liu et al. Journal of Neuroinflammation 2014, 11:47 http://jneuroinflammation/content/11/1/Page 11 of35. Pacher P, Beckman JS, Liaudet L: Nitric oxide and peroxynitrite in overall health and illness. Physiol Rev 2007, 87:315?24. 36. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR: A comparative examination from the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 2012, 26:469?79. 37. Baumann P, Ulrich S, Eckermann G, Gerlach M, Kuss HJ, Laux G, Muller-Oerlinghausen B, Rao ML, Riederer P, Zernig G, Hiemke C: The AGNP-TDM Specialist Group Consensus Recommendations: focus on therapeutic monitoring of antidepressants. Dialogues Clin Neurosci 2005, 7:231?47. 38. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649?83. 39. Liu D, Wang Z, Liu S, Wang F, Zhao S, Hao A: Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells.8-Hydroxyoctanoic acid site Neuropharmacology 2011, 61:592?99.Price of 2,4-Dichloro-5,6-dimethylpyrimidine 40.PMID:24406011 Jung HW, Chung YS, Kim YS, Park YK: Celastrol inhibits production of nitric oxide and proinflammatory cytokines by means of MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells. Exp Mol Med 2007, 39:715?21. 41. Wang MJ, Lin WW, Chen HL, Chang YH, Ou HC, Kuo JS, Hong JS, Jeng KC: Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci 2002, 16:2103?112. 42. Hou RC, Chen HL, Tzen JT, Jeng KC: Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport 2003, 14:1815?819. 43. Svensson C, Fernaeus SZ, Part K, Reis K, Land T: LPS-induced iNOS expression in Bv-2 cells is suppressed by an oxidative mechanism acting on the JNK pathway – a prospective role for neuroprotection. Brain Res 2010, 1322:1?. 44. Kacimi R, Giffard RG, Yenari MA: Endotoxin-activated microglia injure brain derived endothelial cells by means of NF-kappaB, JAK-STAT and JNK strain kinase pathways. J Inflamm 2011.